Literature DB >> 30102884

A systems-based model of Alzheimer's disease.

Yi Tang1, Michael W Lutz2, Yi Xing3.   

Abstract

The new National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease has been developed to accelerate drug discovery and offer a common structure and language to construct new Alzheimer's disease conceptual models. However, as a "complex" disease, a model based on systems-level understanding is needed to accommodate the complex, interacting etiologic pathways and the system-level changes associated with Alzheimer's disease pathogenesis and interventions that are currently known and which will be identified in the future. To accomplish this, the evolution of the structure of the research framework itself should be encouraged.
Copyright © 2018 the Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Common pathway; Model; NIA-AA research framework; Systems biology

Mesh:

Year:  2018        PMID: 30102884     DOI: 10.1016/j.jalz.2018.06.3058

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  4 in total

Review 1.  Delineation of Neuroprotective Effects and Possible Benefits of AntioxidantsTherapy for the Treatment of Alzheimer's Diseases by Targeting Mitochondrial-Derived Reactive Oxygen Species: Bench to Bedside.

Authors:  Vaibhav Walia; Deepak Kaushik; Vineet Mittal; Kuldeep Kumar; Ravinder Verma; Jatin Parashar; Rokeya Akter; Md Habibur Rahman; Saurabh Bhatia; Ahmed Al-Harrasi; Chenmala Karthika; Tanima Bhattacharya; Hitesh Chopra; Ghulam Md Ashraf
Journal:  Mol Neurobiol       Date:  2021-11-09       Impact factor: 5.682

2.  Lipidomic Network of Mild Cognitive Impairment from the Mayo Clinic Study of Aging.

Authors:  Xuewei Wang; Hai Bui; Prashanthi Vemuri; Jonathan Graff-Radford; Clifford R Jack; Ronald C Petersen; Michelle M Mielke
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.160

3.  TRanscranial AlterNating current Stimulation FOR patients with Mild Alzheimer's Disease (TRANSFORM-AD study): Protocol for a randomized controlled clinical trial.

Authors:  Yi Xing; Penghu Wei; Changming Wang; Yi Shan; Yueying Yu; Yuchen Qiao; Beijia Xie; Xinrui Shi; Zhongfang Zhu; Jie Lu; Guoguang Zhao; Jianping Jia; Yi Tang
Journal:  Alzheimers Dement (N Y)       Date:  2020-04-07

4.  Mapping the multicausality of Alzheimer's disease through group model building.

Authors:  Jeroen F Uleman; René J F Melis; Rick Quax; Eddy A van der Zee; Dick Thijssen; Martin Dresler; Ondine van de Rest; Isabelle F van der Velpen; Hieab H H Adams; Ben Schmand; Inge M C M de Kok; Jeroen de Bresser; Edo Richard; Marcel Verbeek; Alfons G Hoekstra; Etiënne A J A Rouwette; Marcel G M Olde Rikkert
Journal:  Geroscience       Date:  2020-08-11       Impact factor: 7.713

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.